Keyword: Emory University
Human-generated antibodies have provided new clues that could boost the development of a broadly protective antiviral drug and universal flu vaccine.
The founder of Mint.com believes he can do for the hospital emergency room what he did for banking and budgets.
A new screening system confirmed that an emerging class of cancer drugs called IAP antagonists have immune-boosting powers.
Capitalizing on a process the body uses to eliminate overly aggressive T cells could be a new way to treat autoimmune diseases.
Sanofi VP Riccardo Perfetti has jumped to metabolic disease startup Applied Therapeutics to become its CMO as it moves into first-in-human trials.
Itaconate, a compound produced by inflammatory cells, relieved psoriasis-like symptoms in mice.
Instead of seeking the underlying cause of a group of symptoms, scientists started with a mutation and then tracked down people who have it.
Checkpoint inhibitors like Merck’s Keytruda don’t work for many patients, and no one knows exactly why. Now, scientists at Emory say they’ve found a clue.
Scientists at Emory University’s Winship Cancer Institute are on a mission to unlock the mysteries of lung cancer cells that have long been thought to be unresponsive to any drug therapy. So they’ve developed what they call a “spiderweb of interactions” between proteins in those cancer cells, and they’re using the data to figure out how to target cancer mutations in the lung.
In a small study involving 20 patients, a team at Emory University says they successfully used cryoablation therapy--cold blasts--to successfully treat phantom limb pain. "Until now, individuals...